日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

HERV-K TM Subunit Elicits CD8(+) T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC.

HERV-K TM 亚基通过靶向 AML 和 PDAC 中的 CD3 共受体 α 引发 CD8(+) T 细胞无反应性和肿瘤免疫逃逸。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202417432
Li Mengyuan, Zheng Shuwen, Gong Qinyuan, Wu Zhaoxing, Lei Wen, Cao Wanyue, Wang Ping, Zhang Xuzhao, Qian Wenbin, Liang Yun, Lu Ying, Li Fenglin, Zhang Qi, Xu Rongzhen
细胞生物学
T细胞
CD8
CD3
肿瘤免疫
发表日期：2026
文献求助 收藏

Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study

以泽布替尼为基础的方案作为复发或难治性非生发中心B细胞样弥漫性大B细胞淋巴瘤CAR-T细胞疗法的挽救或桥接治疗：一项回顾性多中心队列研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1806191
Lu, Yan; Ye, Shiguang; Zhou, Lili; Yuan, Xianggui; Li, Ping; Qian, Wenbin; Liang, Aibin
T细胞
T细胞
免疫/内分泌
B细胞
淋巴瘤
细胞生物学
发表日期：2026
文献求助 收藏

Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 study

达雷妥尤单抗治疗方案在中国多发性骨髓瘤患者中的治疗模式、疗效和安全性：真实世界 MMY4032 研究的长期随访

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06972-8
Yang, Wei; Wang, Luqun; Wang, Yafei; Niu, Ting; Fu, Rong; Zhong, Yuping; Qian, Wenbin; Ding, Kaiyang; Sun, Kai; Liu, Hong; Fang, Baijun; Liu, Hui; Li, Yanhui; Yang, Yishen; Zhuo, Jianmin; Chen, Xi; Xun, Bijie; Lu, Jin
多发性骨髓瘤
骨髓瘤
发表日期：2026
文献求助 收藏

Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

作者更正：4-1BB共刺激CD19特异性CAR-NK细胞疗法治疗难治性/复发性大B细胞淋巴瘤的安全性和可行性：一项I期试验

期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-01026-w
Lei, Wen; Liu, Hui; Deng, Wenhai; Chen, Wei; Liang, Yun; Gao, Wenxia; Yuan, Xianggui; Guo, Shanshan; Li, Ping; Wang, Jinyong; Tong, Xiangmin; Sun, Yi Eve; Liang, Aibin; Qian, Wenbin
免疫/内分泌
B细胞
CD19
淋巴瘤
细胞生物学
CAR-NK
发表日期：2025
文献求助 收藏

Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial

4-1BB共刺激CD19特异性CAR-NK细胞疗法治疗难治性/复发性大B细胞淋巴瘤的安全性和可行性：一项I期试验

期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-00940-3
Lei, Wen; Liu, Hui; Deng, Wenhai; Chen, Wei; Liang, Yun; Gao, Wenxia; Yuan, Xianggui; Guo, Shanshan; Li, Ping; Wang, Jinyong; Tong, Xiangmin; Sun, Yi Eve; Liang, Aibin; Qian, Wenbin
B细胞
淋巴瘤
细胞生物学
CAR-NK
CD19
免疫/内分泌
发表日期：2025
文献求助 收藏

CD33(KO)-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia

CD33(KO)-CD33-间皮素环状CAR设计避免了同胞相残杀，并提高了iNK细胞对抗急性髓系白血病的疗效。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011887
Wang, Yao; Zheng, Xiujuan; Wang, Zhiqian; Xiao, Ziyun; Lin, Yunqing; Zhang, Fan; Liu, Yanhong; Liu, Pengcheng; Weng, Qitong; Zhang, Leqiang; Xia, Chengxiang; Huang, Dehao; Liu, Lijuan; Zhu, Yanping; Zhang, Qi; Qi, Hanmeng; Chen, Yi; Shen, Yiyuan; Zhang, Chenyuan; Xu, Jiacheng; Zhao, Yaoqin; Wu, Jiaxin; Wang, Tongjie; Zhang, Mengyun; Li, Minming; Qian, Wenbin; Liang, Aibin; Du, Xin; Yang, Wenyu; Hu, Tianyuan; Chen, Qi; Zhu, Xiaofan; Hu, Fangxiao; Wang, Jinyong
白血病
细胞生物学
CD33
CD3
发表日期：2025
文献求助 收藏

Histone demethylases in autophagy and inflammation

自噬和炎症中的组蛋白去甲基化酶

期刊:Cell Communication and Signaling
影响因子:8.9
doi:10.1186/s12964-024-02006-w
Ma, Yaoyao; Lv, Wenting; Guo, Yi; Yin, Tong; Bai, Yujie; Liu, Ziqi; Chen, Chao; WenjuanYang; Feng, Jiayi; Qian, Wenbin; Tang, Ruiling; Su, Yanting; Shan, Shigang; Dong, Huifen; Bao, Yongfen; Qu, Lihua
炎症/感染
炎症
表观遗传
自噬
发表日期：2025
文献求助 收藏

A novel BaEVRless-LV packaging system for the production of lentiviral vectors for clinical-grade CAR-NK cell manufacturing

一种用于生产临床级CAR-NK细胞制造用慢病毒载体的新型BaEVRless-LV包装系统

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0551
Zhang, Yinyin; Zhang, Minghuan; Li, Mengyuan; Zong, Lihong; Ye, Qian; Lei, Wen; Deng, Wenhai; Qian, Wenbin
微生物学
细胞生物学
CAR-NK
发表日期：2025
文献求助 收藏

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

提高嵌合抗原受体T细胞疗法治疗淋巴瘤免疫疗效的策略进展

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2024.0538
Yu, Tianshu; Wang, Xianhuo; Bai, Ou; Zhang, Huilai; Qian, Wenbin
T细胞
信号转导
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment

表达抗CD47纳米抗体的溶瘤痘苗病毒通过介导淋巴瘤肿瘤微环境中先天性和适应性免疫细胞的浸润和激活，发挥增强的抗肿瘤活性。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.286923
Li, Mengyuan; Zhang, Yinyin; Zong, Lihong; Zhang, Minghuan; Wang, Shibing; Lei, Wen; Qian, Wenbin
肿瘤
T细胞
肿瘤免疫
CD47
淋巴瘤
微生物学
细胞生物学
肿瘤微环境
CD4
免疫/内分泌
发表日期：2025
文献求助 收藏